Table 5 |
|||
|
Within group effects: Planned risk reduction strategies across with the decision aid |
|||
|
Planned CHD Interventions |
In Decision Aid Group (n = 41) |
||
|
|
|||
|
Baseline |
Post-DA |
Absolute Difference (95% CI) * |
|
|
|
|||
|
BP med, if HTN (n = 13) |
8% |
54% |
+46% (9% to 75%) |
|
Cholesterol med, If abnormal chol (n = 19) |
5% |
26% |
+21% (-5% to 47%) |
|
Smoking cessation, if smoking (n = 19) |
21% |
37% |
+16% (-15% to 44%) |
|
Aspirin, If high risk (> 10%; n = 17) |
6% |
53% |
+47% (19% to 72%) |
|
Diet low in saturated fat, all (n = 41) |
27% |
37% |
+10% (-8% to 27%) |
|
Exercise regularly, all (n = 41) |
29% |
34% |
+5% (-12% to 21%) |
|
|
|||
|
*Exact binomial 95% CI |
|||
|
Sheridan et al. BMC Health Services Research 2006 6:121 doi:10.1186/1472-6963-6-121 |
|||